Entry of taxonomy/keywords during proffered abstract submission was optional.
Not all abstracts will appear in search results.
|SU-F-KDBRB1-2||Tumor Targeting and Cancer Cell Penetrating Theranostic Gadolinium Nanoparticles for Image-Guided Nanoparticle-Enhanced Radiation Therapy|
W Liu*, J Deacon , H Yan , B Sun , Y Liu , D Hegan , K Roberts , P Glazer , Z Chen , R Nath , Yale University and Yale-New Haven Hospital, New Haven, CT
|WE-AB-DBRA-11||Biodistribution and Pharmacokinetic Analysis of a Targeted Alpha Particle Therapy|
Christopher J. Tichacek1,2,3*, Mikalai M. Budzevich4 , Narges K. Tafreshi3 , Thaddeus J. Wadas5 , Mark L. McLaughlin6,7 , David L. Morse2,4,8 , Eduardo G. Moros1,2,3 , (1) Dept. of Radiation Oncology, Moffitt Cancer Center, Tampa, FL, (2) Dept. of Physics, University of South Florida, Tampa, FL, (3) Dept. of Cancer Physiology, Moffitt Cancer Center, Tampa, FL, (4) Small Animal Imaging Laboratory, Moffitt Cancer Center, Tampa, FL, (5) Dept. of Cancer Biology, Wake Forest University Health Sciences, Winston-Salem, NC, (6) Dept. of Pharmaceutical Sciences, West Virginia University, Health Sciences Center, Morgantown, WV, (7) Modulation Therapeutics Inc., Morgantown, WV, (8) Dept. of Oncologic Sciences, University of South Florida, Tampa, FL.
|WE-C1000-GePD-F4-1||Accuracy of Predicting Post-Therapy Exposure Rate and Clearance Effective Half-Life of 131I-Metaiodobenzylguanidine From Dosimetric Study Measurements|
W Erwin*, R Wendt, UT MD Anderson Cancer Center, Houston, TX